NEW YORK – As one of seven projects funded by the US National Institutes of Health to
address the COVID-19 pandemic, Vibrent Health’s COVID-CARE program will soon be rolling
out nationwide to provide screening and testing for COVID-19.
The digital health company, with a stated focus on furthering precision medicine and research
through digital tools, received its initial grant from NIH in September as part of the institute’s
effort to support digital health solutions to address the pandemic. The National Cancer Institute
and National Institute of Biomedical Imaging and Bioengineering selected the projects out of
nearly 200 applications.
Fairfax, Virginia-based Vibrent Health then received the second grant, with both grants totaling
$4 million, in June after completing phase one of its NIH project, which required organizations to
demonstrate feasibility of the project. It is now finishing up its phase two stage, aiming for
commercial launch in the fall, Vibrent CEO Praduman Jain said.
Read more at 360dx.
